Key facts
- Notable investors include Jolmo Investment, China Growth Capital, Shengzou Rubber & Plastic, TopOlefin Technology, Xinhuachuang Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Butterfly Pharmaceutical Packaging
- ·The full record, as it builds
Funding rounds
No funding rounds for Butterfly Pharmaceutical Packaging are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Butterfly Pharmaceutical Packaging
Manufacturer of silicone-free polymer pre-filled syringes intended for medical use. The company offers high-purity pre-filled syringe technologies, GMP-compliant production environments and precision-engineered components, enabling biopharmaceutical manufacturers, hospital networks and clinical research organizations to ensure consistent product integrity and elevate patient care standards.
- Sector
- Healthcare
- HQ
- Nanjing, China
- Founded
- 2022
- Website
- butterflypp.com/
- Ownership
- Privately Held (backing)
Butterfly Pharmaceutical Packaging doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Butterfly Pharmaceutical Packaging shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Butterfly Pharmaceutical Packaging in its N-PORT filings yet. We sweep new filings monthly.